Chronic pain is complex and difficult to treat. Prescribing opioid pain medications has become controversial but may help ...

Documents show that the company that facilitated purchase of children’s pain medication and a pair of proposed surgical facilities share a common owner ...

With the goal of informing clinician practice, a new study explores the harms and benefits of continuing and of discontinuing the long-term prescription of opioid medicines to adults with chronic pain ...

On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...

The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

Research is unclear on whether CoQ10 supplements can help your heart health or help relieve muscle pain ... and statin medications. People with certain conditions may have lower levels of a ...

It can result from underlying conditions, such as kidney failure, or other factors, including drinking too much water or taking certain medications. Health experts define a low sodium level in the ...

In each specialty each of the physicians who were observed is represented by a separate letter. Each physician was observed on either one or two occasions. 1 Dept of Cardiology, Auckland City ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty big deal,” Gupta said. “As you just mentioned, it’s been ...

The use of Journavx for moderate to severe pain has not been studied beyond 14 days. The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to ...